Aberrant LRP16 protein expression in primary neuroendocrine lung tumors

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 6, 2015, Pages 6560-6565

  Shao, Yun ^a,b   Li, Xiaoying ^a   Lu, Yali ^a   Liu, Lin ^a   Zhao, Po ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Department of Pathology Chinese People's Liberation Army (PLA) 307 Hospital   (China)

Author keywords

Immunohistochemistry; LRP16; Neuroendocrine lung tumors; Prognosis

Indexed keywords

LRP16 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

CANCER GRADING; CANCER STAGING; CARCINOMA, NEUROENDOCRINE; CHEMISTRY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

BIOMARKERS, TUMOR; CARCINOMA, NEUROENDOCRINE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM PROTEINS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84938650900     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Travis WD. The concept of pulmonary neuroendocrine tumours. In: Travis WD, Brambilla E, Muller-Hermelink KH, Harris CC, editors. Pathology and Genetics of Tumours of the Lung, Pleura Thymus and Heart. Lyon: IARC; 2004. pp. 19-20.
2. Asamura H, Kameya T, Matsuno Y, Noguchi M, Tada H, Ishikawa Y, Yokose T, Jiang SX, Inoue T, Nakagawa K, Tajima K, Nagai K. Neuro-endocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 2006; 24: 70-76.
3. Rossi G, Cavazza A, Marchioni A, Longo L, Migaldi M, Sartori G, Bigiani N, Schirosi L, Casali C, Morandi U, Facciolongo N, Maiorana A, Bavieri M, Fabbri LM, Brambilla E. Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung. J Clin Oncol 2005; 23: 8774-8785.
4. Simon GR, Wagner H. Small cell lung cancer. Chest 2003; 123: 259S-271S.
5. Sturm N, Rossi G, Lantuejoul S, Laverrière MH, Papotti M, Brichon PY, Brambilla C, Brambilla E. 34BetaE12 expression along the whole spectrum of neuroendocrine proliferations of the lung, from neuroendocrine cell hyperplasia to small cell carcinoma. Histopathology 2003; 42: 156-166.
6. Zhao YL, Han WD, Li Q, Mu YM, Lu XC, Yu L, Song HJ, Li X, Lu JM, Pan CY. Mechanism of transcriptional regulation of LRP16 gene expression by 17-beta estradiol in MCF-7 human breast cancer cells. J Mol Endocrinol 2005; 34: 77-89.
7. Yu L, Han WD, Lou FD, Wang QS, Zhao Y, Caligiuri MA. Cloning of leukemia associated gene LRP16 in acute myeloid leukemia. Junyi Jinxiu Xueyuan Xuebao 2000; 21: 81-84.
8. Han WD, Yu L, Lou FD, Wang QS, Zhao Y, Shi ZJ, Jiao HY, Zhou JJ. Cloning and expression characterization of the full length cDNA for a novel leukemia-associated gene LRP16. Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao 2001; 17: 209-214.
9. Han WD, Lou FD, Yu L, Wang QS, Han XP, Li XJ. SAGE pattern of LRP16 gene and its expression in normal blood and leukemia cells. Junyi Jinxiu Xueyuan Xuebao 2002; 23: 161-163.
10. Han WD, Mu YM, Lu XC, Xu ZM, Li XJ, Yu L, Song HJ, Li M, Lu JM, Pan CY. Estrogen stimulates human breast cancer MCF-7 cell proliferation by up-regulation of LRP16 mRNA via activation of estrogen receptor-alpha. Zhonghua Neifenmi Daixie Zazhi 2004; 20: 165-168.
11. Han WD, Mu YM, Lu XC, Xu ZM, Li XJ, Yu L, Song HJ, Li M, Lu JM, Zhao YL, Pan CY. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report. Endocr Relat Cancer 2003; 10: 217-224.
12. Han WD, Zhao YL, Meng YG, Zang L, Wu ZQ, Li Q, Si YL, Huang K, Ba JM, Morinaga H, Nomura M, Mu YM. Estrogenically regulated LRP16 interacts with estrogen receptor alpha and enhances the receptor's transcriptional activity. Endocr Relat Cancer 2007; 14: 741-753.
13. Wu Z, Li Y, Li X, Ti D, Zhao Y, Si Y, Mei Q, Zhao P, Fu X, Han W. LRP16 integrates into NF-κB transcriptional complex and is required for its functional activation. PLoS One 2011; 6: e18157.
14. Li YZ, Zhao P, Han WD. Clinicopathological significance of LRP16 protein in 336 gastric carcinoma patients. World J Gastroenterol 2009; 15: 4833-4837.
15. Xi HQ, Zhao P, Han WD. Clinicopathological significance and prognostic value of LRP16 expression in colorectal carcinoma. World J Gastroenterol 2010; 16: 1644-1648.
16. Haley KJ, Patidar K, Zhang F, Emanuel RL, Sunday ME. Tumor necrosis factor induces neuroendocrine differentiation in small cell lungcancer cell lines. Am J Physiol 1998; 275: L311-321.
17. Li YD, Liu YP, Cao DM, Yan YM, Hou YN, Zhao JY, Yang R, Xia ZF, Lu J. Induction of small G protein RhoB by non-genotoxic stress inhibits apoptosis and activates NF-κB. J Cell Physiol 2011; 226: 729-738.
18. Kraus AC, Ferber I, Bachmann SO, Specht H, Wimmel A, Gross MW, Schlegel J, Suske G, Schuermann M. In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways. Oncogene 2002; 21: 8683-8695.
19. Li X, Zhu W, Chen Z, Luo L, Huang J, Zhang F, Li M, Guo Y, Guo L. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway. Anticancer Drugs 2014; 25: 1152-1164.
20. Li Z, Guo Y, Jiang H, Zhang T, Jin C, Young CY, Yuan H. Differential regulation of MMPs by E2F1, Sp1 and NF-kappa B controls the small cell lung cancer invasive phenotype. BMC Cancer 2014; 14: 276.